ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
Markets/EquitiesArticle

Natura Q2 2026 outlook dimmed by Brazil weakness, Latin gains

Brazil’s economic slowdown offsets growth in Hispanic markets for Natura’s Q2 2026 projections, according to internal slides reviewed by Reuters.

PA
Priya Anand · Equities & Earnings Desk · 14 Aug 2026 · 1 min read
Share
Natura Q2 2026 outlook dimmed by Brazil weakness, Latin gains

Brazilian cosmetics giant Natura & Co’s Q2 2026 outlook has been tempered by weaker-than-expected performance in its domestic market, though gains in Hispanic regions provided partial offset, according to company slides reviewed by Reuters.

The slides, dated July 2024, indicate that Brazil’s economic slowdown—amid high inflation and subdued consumer spending—has weighed on Natura’s near-term revenue trajectory. Analysts note that the company’s reliance on Latin American markets, particularly Brazil, remains a structural vulnerability despite its expansion into Hispanic communities in the U.S. and Europe.

In contrast, Natura highlighted stronger momentum in Hispanic markets, where demand for its Aesop and The Body Shop brands has outpaced broader regional averages. The company attributed this to targeted marketing strategies and localized product offerings tailored to Hispanic consumer preferences.

Financial targets for Q2 2026 were not disclosed in the slides, and Natura did not immediately respond to requests for comment. The outlook reflects internal projections and may not account for external macroeconomic shifts, including currency volatility or regulatory changes.

Investors will closely monitor Natura’s ability to balance Brazil’s challenges with growth in Hispanic markets, as the company navigates a complex operating environment.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT